Doxycycline in early pregnancy linked to higher loss risk

• More than 218,230 patients received treatment for respiratory tract infections.
• More than 6,630 received treatment for acne.
• About 4,385 filled a doxycycline prescription during that window; comparison patients received an alternative antibiotic.

How did the antibiotic comparisons differ?

Results depended on the infection and the comparison antibiotic:

• For respiratory infections, patients prescribed doxycycline had a 40% to 54% higher risk than those prescribed amoxicillin, another broad-spectrum antibiotic in a different class. The exact estimate varied between databases.
• Against macrolides, a class that includes azithromycin, sold as Z-Pak, the reported increases were 39% and 36% across the two databases.
• Among acne patients, doxycycline users had a 49% higher risk than those given clindamycin in one database. The difference in the second database was not statistically significant, meaning the data did not provide strong evidence of an increase. Winterstein said the smaller patient group may explain that result.
• Overall, the study associated doxycycline with seven to 11 additional pregnancy losses per 100 pregnancies compared with the other options assessed.

Could doxycycline cause pregnancy loss?

Researchers cannot yet say. Because the study was observational, meaning researchers observed exposures and outcomes without assigning treatments, it could not prove that doxycycline itself caused the losses.

The pregnancy losses included miscarriages and stillbirths. Miscarriage means pregnancy loss before 20 weeks, while stillbirth refers to loss after the 20th week.

Luke Grzeskowiak, an associate professor and clinical pharmacist at Flinders University in Australia who did not conduct the study, said animal studies suggest the drug could interfere with early placental development. The placenta is the organ that supports a growing pregnancy.

Grzeskowiak said: “Pregnancy loss affects around one in four pregnancies and can happen for many reasons.”

Although doxycycline exposure may add to that risk, taking the antibiotic does not necessarily mean a pregnancy will be lost; the available data treats exposure as one risk factor among many.

The study authors also raised possible direct effects on the developing embryo. Neither proposed mechanism has been established in humans.

A separate safety concern involves doxycycline's antibiotic class, which can bind to calcium in developing bones. Clinicians generally avoid prescribing it during the second and third trimesters, and animal studies suggest this may disrupt fetal bone development. That issue does not resolve the early-pregnancy signal.

What should clinicians and patients consider?\n

Because doxycycline may be prescribed before a pregnancy is recognized, Grzeskowiak suggested that doctors consider the possibility of pregnancy when treating women of reproductive age, particularly those who are sexually active. He emphasized that this guidance does not call for avoiding doxycycline. Instead, clinicians should weigh pregnancy plans and medical history when choosing treatment.

For severe infection, Winterstein said doxycycline may still be the best option because the infection itself can threaten a pregnancy. For less-serious infections, safer alternatives may be available.

The study therefore points to individualized prescribing rather than a blanket prohibition. It identifies a risk signal, not a settled cause, and leaves the decision with clinicians and their patients.

This article provides information, not medical advice.